神经科

订阅

MedSci主页 / 所有栏目 / 神经科

Neurology：双能 CT 鉴别出血和造影剂渗出

2019-10-29 佚名 脑血管病及重症文献导读

造影剂CT脑出血
关注

示例：右侧 MCA M1闭塞血管内治疗并右侧颈内动脉放置支架后13h。

示例：右侧 MCA M1闭塞血管内治疗并右侧颈内动脉放置支架后13h。

平扫 CT 显示PH1*和 HI2**（图 A），水加权双能 CT 显示无脑出血（图 B），碘加权双能 CT 显示造影剂着色（图 C）：



原始出处：Almqvist H1, Holmin S2, Mazya MV2. Dual energy CT after stroke thrombectomy alters assessment of hemorrhagic complications. Neurology. 2019 Sep 10；

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2000902, encodeId=ec7e200090279, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Jun 28 03:34:00 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374685, encodeId=de283e468506, content=双能C丅低剂量的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 01 20:23:46 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494126, encodeId=7d57149412695, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Thu Oct 31 08:34:00 CST 2019, time=2019-10-31, status=1, ipAttribution=)]
    2020-06-28 yinhl1978

    #Neurol#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2000902, encodeId=ec7e200090279, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Jun 28 03:34:00 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374685, encodeId=de283e468506, content=双能C丅低剂量的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 01 20:23:46 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494126, encodeId=7d57149412695, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Thu Oct 31 08:34:00 CST 2019, time=2019-10-31, status=1, ipAttribution=)]
    2019-11-01 jyzxjiangqin

    双能C丅低剂量的治疗。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2000902, encodeId=ec7e200090279, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Jun 28 03:34:00 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374685, encodeId=de283e468506, content=双能C丅低剂量的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 01 20:23:46 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1494126, encodeId=7d57149412695, content=<a href='/topic/show?id=3e34949e333' target=_blank style='color:#2F92EE;'>#造影#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94973, encryptionId=3e34949e333, topicName=造影)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=908d9134595, createdName=sodoo, createdTime=Thu Oct 31 08:34:00 CST 2019, time=2019-10-31, status=1, ipAttribution=)]
    2019-10-31 sodoo

    #造影#

    0

相关资讯

CCLM：在对比增强诊断成像之前进行肾功能测量即时肌酸酐

眼底血管造影剂致尿总蛋白定量检测结果异常一例

患者女，58岁。因“3个月前无明显诱因出现视物模糊，无复视，视力下降”来复旦大学附属中山医院就诊。

FDA批准Gadavist注射液作为心脏磁共振（MR）成像的造影剂

拜耳公司近日宣布，美国FDA了批准Gadavist®（钆布醇）注射液用于心脏磁共振（MR）成像，以评估已知或疑似具有心肌灌注和冠状动脉疾病（CAD）的成人患者。Gadavist现在是FDA批准用于心脏MR的第一个也是唯一的造影剂。

Crit Care：造影剂对脓毒症相关的急性肾损伤患者肾功能和预后影响

由此可见，单次给予造影剂与脓毒症患者AKI恶化或短期/长期死亡率增加无关。

JACC：生物阻抗指导的水化对于预防造影剂肾病有益吗？

血管内容量扩张在预防造影剂引起的急性肾损伤（CI-AKI）中起主要作用。手术前的静脉注射推荐标准量不会使初始水化状态不同的受试者产生同质应答。2018年6月，发表在《J Am Coll Cardiol》的一项研究调查了生物阻抗指导的水化对于预防造影剂导致的肾损伤的作用。

造影剂、胺碘酮与甲状腺那碘事儿

碘是甲状腺激素的重要原料。根据2015年美国甲状腺协会（ATA）声明，正常成年人每天应摄入约0.15 mg碘元素，孕期妇女应该保持在0.22～0.25mg之间，哺乳期妇女则为0.25～0.29 mg。正常成人每日摄入量超过1.1 mg可能会导致甲状腺功能异常。对于妊娠与哺乳期妇女，考虑到过量的碘对胎儿或婴儿甲状腺的影响，碘摄取上限在0.5～1.1 mg之间。